Clinical Trial Update: A Phase 1 Study of BB102 in Participants With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

This clinical trial update notes that BB102 is being studied in a Phase 1 trial for participants with advanced solid tumors and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• BB102

Snippet

Sponsor: Broadenbio Ltd., Co. | Conditions: Advanced Solid Tumor | Phase 1 | Status: RECRUITING